Schrodinger Quarterly Balance Sheet
NASDAQ: SDGRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Schrodinger financial position
As of Jun 30, 2026, Schrodinger reported total assets of $640.4 million, down 7.0% from a year earlier against total liabilities of $311.4 million. Shareholders' equity stood at $329.0 million, or 51.4% of assets. The company held $287.9 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 2.71, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Schrodinger balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 287.85M | 260.25M | 230.52M | 172.12M | 219.90M | 326.00M | 147.33M | 160.42M | 108.11M | 130.24M | 155.31M | 249.38M |
| Short-Term Investments | 125.89M | 138.70M | 164.95M | 219.11M | 230.28M | 174.30M | 204.80M | 228.26M | 269.18M | 300.84M | 307.69M | 246.91M |
| Receivables | 21.39M | 27.25M | 83.04M | 29.38M | 10.07M | 20.35M | 235.69M | 13.28M | 11.85M | 19.84M | 65.99M | 19.88M |
| Total Current Assets | 470.48M | 463.96M | 519.26M | 471.72M | 514.00M | 570.94M | 634.99M | 456.40M | 449.18M | 493.69M | 567.80M | 547.76M |
| Property, Plant & Equipment | 19.46M | 20.45M | 19.46M | 20.74M | 21.71M | 22.94M | 24.20M | 24.92M | 25.72M | 26.13M | 23.32M | 22.50M |
| Goodwill | 4.79M | 4.79M | 4.79M | 4.79M | 4.79M | 4.79M | 4.79M | 4.79M | 4.79M | 4.79M | 4.79M | 4.79M |
| Intangible Assets | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Total Assets | 640.39M | 634.19M | 726.16M | 653.66M | 688.24M | 743.03M | 823.23M | 669.30M | 688.37M | 737.76M | 802.96M | 794.15M |
| Accounts Payable | 10.32M | 11.95M | 11.45M | 9.22M | 8.80M | 11.86M | 10.67M | 11.21M | 8.12M | 9.97M | 16.82M | 10.32M |
| Total Current Liabilities | 173.84M | 169.54M | 189.14M | 145.11M | 155.77M | 165.47M | 191.75M | 111.12M | 99.76M | 106.51M | 133.67M | 105.04M |
| Total Liabilities | 311.44M | 320.64M | 362.11M | 332.31M | 345.37M | 369.53M | 401.78M | 219.87M | 214.39M | 224.06M | 254.40M | 230.57M |
| Shareholders' Equity | 328.96M | 313.55M | 364.05M | 321.35M | 342.87M | 373.50M | 421.44M | 449.43M | 473.98M | 513.71M | 548.56M | 563.58M |
| Retained Earnings | -682.86M | -688.83M | -628.81M | -661.32M | -628.52M | -585.35M | -525.54M | -485.32M | -447.19M | -393.14M | -338.42M | -307.75M |
| Net Cash (Debt) | 413.74M | 398.96M | 395.46M | 391.23M | 450.19M | 500.30M | 352.12M | 388.68M | 377.29M | 431.08M | 463.00M | 496.28M |
| Shares Outstanding | — | — | — | — | — | — | — | — | — | — | 62.98M | — |
This table shows 12 quarterly periods of Schrodinger's balance sheet, from Q2 2026 back to Q3 2023, across 15 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow SDGR's reporting calendar. What is a balance sheet?